Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Modifying gut bacteria with oral sialic acid in healthy adults

Official title: Modulation of Gut Microbiota by Oral Sialic Acid: A Mechanistic Study

Run by Army Medical University, China · NCT07162662 · Data updated 2026-11-12

We are testing whether taking oral sialic acid changes the gut microbiome in healthy adults.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment42 (estimated)
SponsorArmy Medical University, China
Academic / other
Locations1 site (Chongqing, Chongqing Municipality)
StatusRecruiting
StartedSeptember 10, 2025
Main results expectedAugust 1, 2026
Study endsAugust 1, 2027
Registry record updatedDecember 10, 2025
Trial IDNCT07162662 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–75 with no major medical conditions, no recent use of antibiotics/probiotics/immunosuppressants, and willing to sign informed consent are the intended participants.

Probably not a fit

People with serious comorbidities, recent severe infections or anti-infective treatment, pregnant or lactating women, or those unable to follow the protocol are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center prospective cohort gives oral sialic acid to healthy volunteers and monitors changes in their gut microbiota over time. Stool samples will be collected serially and analyzed (e.g., sequencing and microbial quantification) with particular attention to growth of pathogens such as Escherichia coli and Klebsiella pneumoniae. Participants are aged 18–75, must be free of major diseases and recent antibiotics, and will be followed according to a predefined protocol. The goal is to clarify how sialic acid intake affects intestinal microbial structure and to inform strategies to preserve or restore intestinal homeostasis.

Why it matters

Potential benefit: If successful, this work could identify how sialic acid intake shifts gut bacteria and suggest ways to prevent pathogen overgrowth and protect intestinal healing.

How similar studies have gone: Preclinical and observational studies suggest sialic acid can feed certain gut pathogens, but controlled human interventional data on oral sialic acid are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 75 years
* No history of major diseases, no previous surgical history, and no history of cardiometabolic diseases (such as hypertension, diabetes mellitus, obesity, etc.)
* No use of drugs that may affect gut microbiota or metabolic function (e.g., antibiotics, probiotics, immunosuppressants, etc.);
* Voluntarily participate in the study and sign the informed consent form.

Exclusion Criteria:

* Comorbidities: Complicated with other severe diseases (e.g., immunodeficiency, chronic liver disease, renal insufficiency, malignant tumors, etc.).
* Recent infections: Registration records indicate a history of severe infections in the recent period (within 3 months) or currently receiving anti-infective treatment.
* Special populations: Pregnant women, lactating women, or women planning to become pregnant.
* Poor compliance: Volunteers who are unable to cooperate with the study protocol or follow-up

Where it's running

  • Second Affiliated Hospital of Army Medical University
    Chongqing, Chongqing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.